The US Bankruptcy Court granted an order for relief for liquidation under Chapter 7 for the involuntary petition filed against Generex Biotechnology Corp. on June 6, 2022. The debtor listed its assets of $338.41 million and liabilities of $521.63 million.
Generex Biotechnology Corporation
Equities
GNBT
US3714853013
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+3.81% | 108B | |
+11.14% | 104B | |
+1.28% | 22.33B | |
-12.86% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.63% | 17.64B | |
+3.77% | 14.05B | |
+37.32% | 12.51B |